Cyclophosphamide versus ifosfamide in paediatric oncology

Trajectory of functional outcome and health status after moderate-to-major trauma in Hong Kong: A prospective 5 year cohort study.

Injury·2019

Trauma team activation criteria and outcomes of geriatric trauma: 10 year single centre cohort study.

The American journal of emergency medicine·2018

Vascularized Tissue-Engineered Model for Studying Drug Resistance in Neuroblastoma.

Theranostics·2017

Acute myeloid leukemia targets for bispecific antibodies.

Blood cancer journal·2017

Comprehensive care programme for patients with chronic obstructive pulmonary disease: a randomised controlled trial.

Thorax·2016

Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2 immunotherapy and isotretinoin: a prospective Phase II study.

Oncoimmunology·2015

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Comparative safety of PICC-ports and chest ports in oncology: A monocentric retrospective cohort study.

The journal of vascular access·2026

Combinatorial effects of curcumin, morin, and phyllanthin in MDA-MB-231 and MCF-7 breast cancer cell lines.

Indian journal of pharmacology·2026

Local Therapy for Isolated Residual Metastatic Melanoma and Renal Cell Carcinoma Following Immune Checkpoint Inhibition Leading to Long-Term Remission.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2026

Cost-effectiveness analysis of liposomal Irinotecan in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas in Greece.

Expert review of pharmacoeconomics & outcomes research·2026

Improving Cognitive Impairment in Cancer Patients With an Online Course in Mindfulness-Based Stress Reduction-A Randomized Controlled Trial.

Psycho-oncology·2026

Cytokine Release Syndrome Induced by Neoadjuvant Pembrolizumab in Early Triple-Negative Breast Cancer: A Case Report with Implications for Early Diagnosis and Management.

Case reports in oncology·2026

Related Experiment Videos

Cyclophosphamide versus ifosfamide in paediatric oncology

Related Concept Videos

Trajectory of functional outcome and health status after moderate-to-major trauma in Hong Kong: A prospective 5 year cohort study.

Trauma team activation criteria and outcomes of geriatric trauma: 10 year single centre cohort study.

Vascularized Tissue-Engineered Model for Studying Drug Resistance in Neuroblastoma.

Acute myeloid leukemia targets for bispecific antibodies.

Comprehensive care programme for patients with chronic obstructive pulmonary disease: a randomised controlled trial.

Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2 immunotherapy and isotretinoin: a prospective Phase II study.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Comparative safety of PICC-ports and chest ports in oncology: A monocentric retrospective cohort study.

Combinatorial effects of curcumin, morin, and phyllanthin in MDA-MB-231 and MCF-7 breast cancer cell lines.

Local Therapy for Isolated Residual Metastatic Melanoma and Renal Cell Carcinoma Following Immune Checkpoint Inhibition Leading to Long-Term Remission.

Cost-effectiveness analysis of liposomal Irinotecan in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas in Greece.

Improving Cognitive Impairment in Cancer Patients With an Online Course in Mindfulness-Based Stress Reduction-A Randomized Controlled Trial.

Cytokine Release Syndrome Induced by Neoadjuvant Pembrolizumab in Early Triple-Negative Breast Cancer: A Case Report with Implications for Early Diagnosis and Management.

Related Experiment Videos

Cyclophosphamide versus ifosfamide in paediatric oncology

Related Concept Videos

Related Articles